-
-
Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery
-
New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques
New webinar added to our brain tumor webinar series: Sunday 9/27/2020 7pm Eastern Time
Assessment of Treatment Response to Established and... -
Return to work following diagnosis of low-grade glioma
-
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
-
GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases
-
Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme
-
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
-
The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
-
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
No content found
Please log in to your account to view your subscribed posts.